EMEA (Europe, Middle East and Africa) Subcutaneous Immunoglobulins Market Report 2017

December 2017 | 105 pages | ID: ED8571C844DEN
QYResearch

Abstracts

In this report, the EMEA Subcutaneous Immunoglobulins market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Subcutaneous Immunoglobulins for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Subcutaneous Immunoglobulins market competition by top manufacturers/players, with Subcutaneous Immunoglobulins sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Grifols S.A
• Octopharma AG
• Biotest AG
• Shire
• CSL Ltd
• Kedrion S.p.A.
• Sanquin

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Immunoglobulin A
• Immunoglobulin E
• Immunoglobulin G
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Immunology
• Oncology
• Pulmonology
• Rheumatology
• Transplant
• Neurology
• Hematology
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Subcutaneous Immunoglobulins Market Report 2017

1 SUBCUTANEOUS IMMUNOGLOBULINS OVERVIEW

1.1 Product Overview and Scope of Subcutaneous Immunoglobulins
1.2 Classification of Subcutaneous Immunoglobulins
  1.2.1 EMEA Subcutaneous Immunoglobulins Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Subcutaneous Immunoglobulins Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Immunoglobulin A
  1.2.4 Immunoglobulin E
  1.2.5 Immunoglobulin G
  1.2.6 Others
1.3 EMEA Subcutaneous Immunoglobulins Market by Application/End Users
  1.3.1 EMEA Subcutaneous Immunoglobulins Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Immunology
  1.3.3 Oncology
  1.3.4 Pulmonology
  1.3.5 Rheumatology
  1.3.6 Transplant
  1.3.7 Neurology
  1.3.8 Hematology
  1.3.9 Others
1.4 EMEA Subcutaneous Immunoglobulins Market by Region
  1.4.1 EMEA Subcutaneous Immunoglobulins Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Subcutaneous Immunoglobulins (2012-2022)
  1.5.1 EMEA Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Subcutaneous Immunoglobulins Revenue and Growth Rate (2012-2022)

2 EMEA SUBCUTANEOUS IMMUNOGLOBULINS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Subcutaneous Immunoglobulins Market Competition by Players/Manufacturers
  2.1.1 EMEA Subcutaneous Immunoglobulins Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Subcutaneous Immunoglobulins Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Subcutaneous Immunoglobulins Sale Price by Players (2012-2017)
2.2 EMEA Subcutaneous Immunoglobulins (Volume and Value) by Type/Product Category
  2.2.1 EMEA Subcutaneous Immunoglobulins Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Subcutaneous Immunoglobulins Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Subcutaneous Immunoglobulins Sale Price by Type (2012-2017)
2.3 EMEA Subcutaneous Immunoglobulins (Volume) by Application
2.4 EMEA Subcutaneous Immunoglobulins (Volume and Value) by Region
  2.4.1 EMEA Subcutaneous Immunoglobulins Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Subcutaneous Immunoglobulins Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Subcutaneous Immunoglobulins Sales Price by Region (2012-2017)

3 EUROPE SUBCUTANEOUS IMMUNOGLOBULINS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Subcutaneous Immunoglobulins Sales and Value (2012-2017)
  3.1.1 Europe Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Subcutaneous Immunoglobulins Revenue and Growth Rate (2012-2017)
3.2 Europe Subcutaneous Immunoglobulins Sales and Market Share by Type
3.3 Europe Subcutaneous Immunoglobulins Sales and Market Share by Application
3.4 Europe Subcutaneous Immunoglobulins Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Subcutaneous Immunoglobulins Sales Volume by Countries (2012-2017)
  3.4.2 Europe Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
  3.4.3 Germany Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2017)
  3.4.4 France Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2017)
  3.4.5 UK Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2017)
  3.4.6 Russia Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2017)
  3.4.7 Italy Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2017)

4 MIDDLE EAST SUBCUTANEOUS IMMUNOGLOBULINS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Subcutaneous Immunoglobulins Sales and Value (2012-2017)
  4.1.1 Middle East Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Subcutaneous Immunoglobulins Revenue and Growth Rate (2012-2017)
4.2 Middle East Subcutaneous Immunoglobulins Sales and Market Share by Type
4.3 Middle East Subcutaneous Immunoglobulins Sales and Market Share by Application
4.4 Middle East Subcutaneous Immunoglobulins Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Subcutaneous Immunoglobulins Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2017)
  4.4.4 Israel Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2017)
  4.4.5 UAE Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2017)
  4.4.6 Iran Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2017)

5 AFRICA SUBCUTANEOUS IMMUNOGLOBULINS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Subcutaneous Immunoglobulins Sales and Value (2012-2017)
  5.1.1 Africa Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Subcutaneous Immunoglobulins Revenue and Growth Rate (2012-2017)
5.2 Africa Subcutaneous Immunoglobulins Sales and Market Share by Type
5.3 Africa Subcutaneous Immunoglobulins Sales and Market Share by Application
5.4 Africa Subcutaneous Immunoglobulins Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Subcutaneous Immunoglobulins Sales Volume by Countries (2012-2017)
  5.4.2 Africa Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
  5.4.3 South Africa Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2017)

6 EMEA SUBCUTANEOUS IMMUNOGLOBULINS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Grifols S.A
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Subcutaneous Immunoglobulins Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Grifols S.A Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Octopharma AG
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Subcutaneous Immunoglobulins Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Octopharma AG Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Biotest AG
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Subcutaneous Immunoglobulins Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Biotest AG Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Shire
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Subcutaneous Immunoglobulins Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Shire Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 CSL Ltd
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Subcutaneous Immunoglobulins Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 CSL Ltd Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Kedrion S.p.A.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Subcutaneous Immunoglobulins Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Kedrion S.p.A. Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sanquin
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Subcutaneous Immunoglobulins Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sanquin Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 SUBCUTANEOUS IMMUNOGLOBULINS MANUFACTURING COST ANALYSIS

7.1 Subcutaneous Immunoglobulins Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Subcutaneous Immunoglobulins

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Subcutaneous Immunoglobulins Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Subcutaneous Immunoglobulins Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA SUBCUTANEOUS IMMUNOGLOBULINS MARKET FORECAST (2017-2022)

11.1 EMEA Subcutaneous Immunoglobulins Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Subcutaneous Immunoglobulins Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Subcutaneous Immunoglobulins Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Subcutaneous Immunoglobulins Price and Trend Forecast (2017-2022)
11.2 EMEA Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Subcutaneous Immunoglobulins Sales Forecast by Type (2017-2022)
11.7 EMEA Subcutaneous Immunoglobulins Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Subcutaneous Immunoglobulins
Figure EMEA Subcutaneous Immunoglobulins Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Subcutaneous Immunoglobulins Sales Volume Market Share by Type (Product Category) in 2016
Figure Immunoglobulin A Product Picture
Figure Immunoglobulin E Product Picture
Figure Immunoglobulin G Product Picture
Figure Others Product Picture
Figure EMEA Subcutaneous Immunoglobulins Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Subcutaneous Immunoglobulins by Application in 2016
Figure Immunology Examples
Table Key Downstream Customer in Immunology
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Pulmonology Examples
Table Key Downstream Customer in Pulmonology
Figure Rheumatology Examples
Table Key Downstream Customer in Rheumatology
Figure Transplant Examples
Table Key Downstream Customer in Transplant
Figure Neurology Examples
Table Key Downstream Customer in Neurology
Figure Hematology Examples
Table Key Downstream Customer in Hematology
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Subcutaneous Immunoglobulins Market Size (Million USD) by Region (2012-2022)
Figure Europe Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Subcutaneous Immunoglobulins Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Subcutaneous Immunoglobulins Revenue (Million USD) Status and Forecast by Countries
Figure Africa Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Subcutaneous Immunoglobulins Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2012-2022)
Figure EMEA Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Subcutaneous Immunoglobulins Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Subcutaneous Immunoglobulins Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Subcutaneous Immunoglobulins Sales Share by Players (2012-2017)
Figure 2016 Subcutaneous Immunoglobulins Sales Share by Players
Figure 2017 Subcutaneous Immunoglobulins Sales Share by Players
Figure EMEA Subcutaneous Immunoglobulins Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Subcutaneous Immunoglobulins Revenue (Million USD) by Players (2012-2017)
Table EMEA Subcutaneous Immunoglobulins Revenue Share by Players (2012-2017)
Table 2016 EMEA Subcutaneous Immunoglobulins Revenue Share by Players
Table 2017 EMEA Subcutaneous Immunoglobulins Revenue Share by Players
Table EMEA Subcutaneous Immunoglobulins Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Subcutaneous Immunoglobulins Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Subcutaneous Immunoglobulins Sales Share by Type (2012-2017)
Figure Sales Market Share of Subcutaneous Immunoglobulins by Type (2012-2017)
Figure EMEA Subcutaneous Immunoglobulins Sales Market Share by Type (2012-2017)
Table EMEA Subcutaneous Immunoglobulins Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Subcutaneous Immunoglobulins Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Subcutaneous Immunoglobulins by Type in 2016
Table EMEA Subcutaneous Immunoglobulins Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Subcutaneous Immunoglobulins Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Subcutaneous Immunoglobulins Sales Share by Application (2012-2017)
Figure Sales Market Share of Subcutaneous Immunoglobulins by Application (2012-2017)
Figure EMEA Subcutaneous Immunoglobulins Sales Market Share by Application in 2016
Table EMEA Subcutaneous Immunoglobulins Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Subcutaneous Immunoglobulins Sales Share by Region (2012-2017)
Figure Sales Market Share of Subcutaneous Immunoglobulins by Region (2012-2017)
Figure EMEA Subcutaneous Immunoglobulins Sales Market Share in 2016
Table EMEA Subcutaneous Immunoglobulins Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Subcutaneous Immunoglobulins Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Subcutaneous Immunoglobulins by Region (2012-2017)
Figure EMEA Subcutaneous Immunoglobulins Revenue Market Share Regions in 2016
Table EMEA Subcutaneous Immunoglobulins Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Subcutaneous Immunoglobulins Revenue and Growth Rate (2012-2017)
Table Europe Subcutaneous Immunoglobulins Sales (K MT) by Type (2012-2017)
Table Europe Subcutaneous Immunoglobulins Market Share by Type (2012-2017)
Figure Europe Subcutaneous Immunoglobulins Market Share by Type in 2016
Table Europe Subcutaneous Immunoglobulins Sales (K MT) by Application (2012-2017)
Table Europe Subcutaneous Immunoglobulins Market Share by Application (2012-2017)
Figure Europe Subcutaneous Immunoglobulins Market Share by Application in 2016
Table Europe Subcutaneous Immunoglobulins Sales (K MT) by Countries (2012-2017)
Table Europe Subcutaneous Immunoglobulins Sales Market Share by Countries (2012-2017)
Figure Europe Subcutaneous Immunoglobulins Sales Market Share by Countries (2012-2017)
Figure Europe Subcutaneous Immunoglobulins Sales Market Share by Countries in 2016
Table Europe Subcutaneous Immunoglobulins Revenue (Million USD) by Countries (2012-2017)
Table Europe Subcutaneous Immunoglobulins Revenue Market Share by Countries (2012-2017)
Figure Europe Subcutaneous Immunoglobulins Revenue Market Share by Countries (2012-2017)
Figure Europe Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2016
Figure Germany Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure France Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure UK Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Subcutaneous Immunoglobulins Sales (K MT) by Type (2012-2017)
Table Middle East Subcutaneous Immunoglobulins Market Share by Type (2012-2017)
Figure Middle East Subcutaneous Immunoglobulins Market Share by Type (2012-2017)
Table Middle East Subcutaneous Immunoglobulins Sales (K MT) by Applications (2012-2017)
Table Middle East Subcutaneous Immunoglobulins Market Share by Applications (2012-2017)
Figure Middle East Subcutaneous Immunoglobulins Sales Market Share by Application in 2016
Table Middle East Subcutaneous Immunoglobulins Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Subcutaneous Immunoglobulins Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Subcutaneous Immunoglobulins Sales Volume Market Share by Countries in 2016
Table Middle East Subcutaneous Immunoglobulins Revenue (Million USD) by Countries (2012-2017)
Table Middle East Subcutaneous Immunoglobulins Revenue Market Share by Countries (2012-2017)
Figure Middle East Subcutaneous Immunoglobulins Revenue Market Share by Countries (2012-2017)
Figure Middle East Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2016
Figure Saudi Arabia Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Subcutaneous Immunoglobulins Sales (K MT) by Type (2012-2017)
Table Africa Subcutaneous Immunoglobulins Sales Market Share by Type (2012-2017)
Figure Africa Subcutaneous Immunoglobulins Sales Market Share by Type (2012-2017)
Figure Africa Subcutaneous Immunoglobulins Sales Market Share by Type in 2016
Table Africa Subcutaneous Immunoglobulins Sales (K MT) by Application (2012-2017)
Table Africa Subcutaneous Immunoglobulins Sales Market Share by Application (2012-2017)
Figure Africa Subcutaneous Immunoglobulins Sales Market Share by Application (2012-2017)
Table Africa Subcutaneous Immunoglobulins Sales Volume (K MT) by Countries (2012-2017)
Table Africa Subcutaneous Immunoglobulins Sales Market Share by Countries (2012-2017)
Figure Africa Subcutaneous Immunoglobulins Sales Market Share by Countries (2012-2017)
Figure Africa Subcutaneous Immunoglobulins Sales Market Share by Countries in 2016
Table Africa Subcutaneous Immunoglobulins Revenue (Million USD) by Countries (2012-2017)
Table Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries (2012-2017)
Figure Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries (2012-2017)
Figure Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries in 2016
Figure South Africa Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Table Grifols S.A Subcutaneous Immunoglobulins Basic Information List
Table Grifols S.A Subcutaneous Immunoglobulins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Grifols S.A Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Grifols S.A Subcutaneous Immunoglobulins Sales Market Share in EMEA (2012-2017)
Figure Grifols S.A Subcutaneous Immunoglobulins Revenue Market Share in EMEA (2012-2017)
Table Octopharma AG Subcutaneous Immunoglobulins Basic Information List
Table Octopharma AG Subcutaneous Immunoglobulins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Octopharma AG Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Octopharma AG Subcutaneous Immunoglobulins Sales Market Share in EMEA (2012-2017)
Figure Octopharma AG Subcutaneous Immunoglobulins Revenue Market Share in EMEA (2012-2017)
Table Biotest AG Subcutaneous Immunoglobulins Basic Information List
Table Biotest AG Subcutaneous Immunoglobulins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Biotest AG Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Biotest AG Subcutaneous Immunoglobulins Sales Market Share in EMEA (2012-2017)
Figure Biotest AG Subcutaneous Immunoglobulins Revenue Market Share in EMEA (2012-2017)
Table Shire Subcutaneous Immunoglobulins Basic Information List
Table Shire Subcutaneous Immunoglobulins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Shire Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Shire Subcutaneous Immunoglobulins Sales Market Share in EMEA (2012-2017)
Figure Shire Subcutaneous Immunoglobulins Revenue Market Share in EMEA (2012-2017)
Table CSL Ltd Subcutaneous Immunoglobulins Basic Information List
Table CSL Ltd Subcutaneous Immunoglobulins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure CSL Ltd Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure CSL Ltd Subcutaneous Immunoglobulins Sales Market Share in EMEA (2012-2017)
Figure CSL Ltd Subcutaneous Immunoglobulins Revenue Market Share in EMEA (2012-2017)
Table Kedrion S.p.A. Subcutaneous Immunoglobulins Basic Information List
Table Kedrion S.p.A. Subcutaneous Immunoglobulins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Kedrion S.p.A. Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Kedrion S.p.A. Subcutaneous Immunoglobulins Sales Market Share in EMEA (2012-2017)
Figure Kedrion S.p.A. Subcutaneous Immunoglobulins Revenue Market Share in EMEA (2012-2017)
Table Sanquin Subcutaneous Immunoglobulins Basic Information List
Table Sanquin Subcutaneous Immunoglobulins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanquin Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2017)
Figure Sanquin Subcutaneous Immunoglobulins Sales Market Share in EMEA (2012-2017)
Figure Sanquin Subcutaneous Immunoglobulins Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Subcutaneous Immunoglobulins
Figure Manufacturing Process Analysis of Subcutaneous Immunoglobulins
Figure Subcutaneous Immunoglobulins Industrial Chain Analysis
Table Raw Materials Sources of Subcutaneous Immunoglobulins Major Manufacturers in 2016
Table Major Buyers of Subcutaneous Immunoglobulins
Table Distributors/Traders List
Figure EMEA Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Subcutaneous Immunoglobulins Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Subcutaneous Immunoglobulins Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Subcutaneous Immunoglobulins Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Subcutaneous Immunoglobulins Sales Market Share Forecast by Region (2017-2022)
Table EMEA Subcutaneous Immunoglobulins Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Subcutaneous Immunoglobulins Revenue Market Share Forecast by Region (2017-2022)
Table Europe Subcutaneous Immunoglobulins Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Subcutaneous Immunoglobulins Sales Market Share Forecast by Countries (2017-2022)
Table Europe Subcutaneous Immunoglobulins Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Subcutaneous Immunoglobulins Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Subcutaneous Immunoglobulins Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Subcutaneous Immunoglobulins Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Subcutaneous Immunoglobulins Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Subcutaneous Immunoglobulins Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Subcutaneous Immunoglobulins Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Subcutaneous Immunoglobulins Sales Market Share Forecast by Countries (2017-2022)
Table Africa Subcutaneous Immunoglobulins Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Subcutaneous Immunoglobulins Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Subcutaneous Immunoglobulins Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Subcutaneous Immunoglobulins Sales Market Share Forecast by Type (2017-2022)
Table EMEA Subcutaneous Immunoglobulins Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Subcutaneous Immunoglobulins Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources